BIOV · BioVaxys Technology Corp. · Financials
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Net Income
-3.95M
+48.6%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2024 | FY2023 |
|---|---|---|
| CAD | -3.95M | -7.69M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.